GlassScriptPhysician profile
Dominic Ho
NPI 1881610582
$2,072.29
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $363 · 2020: $273 · 2021: $382 · 2022: $686 · 2023: $253 · 2024: $117.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $370.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $369.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $514.49 | 2019-2023 | Xarelto |
| Glaxosmithkline, LLC. | $465.65 | 2020-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $220.59 | 2022 | |
| Gilead Sciences, INC. | $177.69 | 2021-2023 | Vemlidy |
| Pfizer INC. | $168.76 | 2021-2023 | |
| Dexcom, INC. | $116.81 | 2024 | Dexcom G7 Gss (161) |
| E.R. Squibb & Sons, L.L.C. | $109.37 | 2022 | |
| Abbvie INC. | $80.93 | 2021-2022 | |
| Amgen INC. | $52.05 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $40.93 | 2021-2022 | |
| Arbor Pharmaceuticals, INC. | $32.69 | 2020 | |
| Otsuka America Pharmaceutical, INC. | $26.51 | 2021-2022 | |
| Corium, LLC | $24.15 | 2022 | |
| Merck Sharp & Dohme LLC | $24.00 | 2021 | |
| Adlon Therapeutics L.P. | $17.67 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dominic Ho listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.